
Senior regulatory and quality leader and trained Responsible Person (GDP) whose career spans consulting for blue-chip pharmaceutical multinationals and leading global quality operations for a FTSE 100 consumer goods business. Deep hands-on experience across medicinal cannabis supply chains, controlled drug compliance, GMP/GDP-regulated operations and CBD novel foods — covering licensing strategy, quality system design, supplier qualification, technical due diligence and operational delivery.
Trusted by founders, boards and investors to bring structure, reduce delivery risk and move complex programmes forward — including market entry, international supply chain build, scale-up, turnaround and restructuring. Works selectively with compliance-focused founders building businesses designed to withstand regulatory scrutiny from day one. Strong at bridging regulators, technical teams, manufacturers and commercial stakeholders to convert strategy into executable, compliant plans.